Following a successful third quarter driven by glucagon uptake and competitor shortages, Amphastar Pharmaceuticals, Inc. management expressed both on its results call and at the 2023 Jefferies Healthcare Conference – held in London in November – that capitalizing on said shortages will remain part of the company’s business strategy for the foreseeable future.
Amphastar manufactures multiple products that are currently in shortage and has found fresh opportunities following the tornado damage at a...




